Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review

BACKGROUND: Numerous reports contend opioids can augment or inhibit malignancy. At present, there is no consensus on the risk or benefit posed by opioids on malignancy or chemotherapeutic activity. Distinguishing the consequences of opioid use from pain and its management is challenging. Additionall...

Descripción completa

Detalles Bibliográficos
Autores principales: Constance, Jonathan E, McFarland, Mary M, Casucci, Tallie, Deininger, Michael W, Enioutina, Elena Y, Job, Kathleen, Lemons, Richard S, Lim, Carol S, Ward, Robert M, Yellepeddi, Venkata, Watt, Kevin M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242459/
https://www.ncbi.nlm.nih.gov/pubmed/37213193
http://dx.doi.org/10.2196/38167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242459/
https://www.ncbi.nlm.nih.gov/pubmed/37213193
http://dx.doi.org/10.2196/38167

Ejemplares similares